Expedia

Expedia: Morgan Stanley maintains Equal-Weight, raises PT to $290 from $270.

Expedia's B2B Expansion Accelerates, Driving Growth and Scalability

Expedia Triggers MACD Death Cross, KDJ Death Cross on 15-Minute Chart

Expedia's 15min chart sees MACD Death Cross, Bollinger Bands Narrowing.

Expedia's 15-minute chart signals MACD and KDJ death crosses.

Risk<ul> <li>Technical indicators show that the market is in a weak state, and we need to pay attention to the risk of decline.</li> <li>Bearish signals are obviously dominant with 4 bearish versus 0 bullish indicators in recent periods.</li></ul>

Key Factors

Expedia Group's B2B gross bookings and revenues grew 24% year-over-year in Q4 2025, driven by strong partner engagement and API infrastructure expansion. Expedia's B2B segment, supported by its Rapid API and new offerings like travel insurance, is central to its platform-led strategy and future revenue growth. Morgan Stanley raised its price target for Expedia to $290 from $270, maintaining its Equal-Weight rating.

EXPE News